ADAPT-2 is a multi-site trial of bupropion plus extended-release naltrexone for adults with methamphetamine use disorder.
City and County of San Francisco Department of Public Health Community Health Equity & Promotion Branch Population Health Division
ADAPT-2 is a multi-site trial of bupropion plus extended-release naltrexone for adults with methamphetamine use disorder.
